Actively Recruiting
Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression
Led by University of Manitoba · Updated on 2025-05-13
20
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the feasibility and acceptability of the intervention, Group Medical Visits (GMVs), for patients with depression and anxiety. It also aims to get some initial information on the effectiveness of GMVs on reducing depression and anxiety scores, which will help inform power calculations for a future larger randomized controlled trial (RCT). The main question it aims to answer is: * Are GMVs feasible and acceptable to patients with depression and anxiety? This study consists of a pilot RCT with an intervention and control arm. At enrollment, participants will be randomized to the intervention group, 6 months of GMVs, or to the control group, which consists of "standard client services". For the GMV group, participants will engage in a biweekly virtual group that is similar to a standard psychiatric follow-up. Participants in the control group will receive standard care after a psychiatric assessment, which includes follow-up with their primary care provider (family physician or nurse practitioner), individual psychiatric care if suggested by the psychiatrist who did their psychiatric assessment, and/or a referral to publicly funded therapy groups if interested.
CONDITIONS
Official Title
Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult Central Intake patients referred for psychiatric consultation by their primary care provider
- Primary mental health issue is an anxiety disorder (social anxiety, generalized anxiety, or panic disorder) or depression (major depressive disorder or persistent depressive disorder)
- Able to participate in English language group with up to 10 participants
- Able to commit to a virtual biweekly group for about 1.5 hours each session
- Able to join virtual group from a private location with camera access
- Live in community in Manitoba and plan to stay for 6-month period
You will not qualify if you...
- Diagnosis of Bipolar 1 or 2 Disorder
- Primary diagnosis of a personality disorder causing anxiety/depression symptoms (personality disorder traits allowed)
- Already have established long-term care with a psychiatrist
- Received ECT treatment within past 6 months
- Diagnosis significantly affecting ability to participate, including moderate-to-severe substance use disorders, current psychotic symptoms, moderate-to-severe intellectual disability or neurocognitive disorder, and significant eating disorder symptoms
- Self-harm requiring medical/psychiatric attention or active suicidal ideation/suicide attempts within past 6 months
- Safety concerns for other group members or facilitators if patient joins
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
PsycHealth Centre
Winnipeg, Manitoba, Canada, R3E 3N4
Actively Recruiting
Research Team
K
Kirsten Penner-Goeke, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here